Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Ahmed Elkhanany"'
Autor:
Ameer Mansur, Moozhan Nikpanah, Johnathan McConathy, Erica Stringer-Reasor, Gabrielle Rocque, Ahmed Elkhanany, Katia Khoury, Nusrat Jahan, Suzanne E. Lapi, Anna G. Sorace
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 139-139 (2024)
OBJECTIVES/GOALS: This study was performed to explore the capabilities of simultaneous [89 Zr]trastuzumab-PET/MRI acquisition in a cohort of metastatic HER2+ breast cancer. The insights derived provide additional noninvasive characterization and prec
Externí odkaz:
https://doaj.org/article/effaf72b545b453f872f48743d8b9f08
Autor:
Neelima Vidula, Andrew Lipman, Shumei Kato, Caroline Weipert, Katherine Hesler, Georges Azzi, Ahmed Elkhanany, Dejan Juric, Estelamari Rodriguez, Colleen Faulkner, Paul Makhlouf, Kristin Price, Joyce O’Shaughnessy, Aditya Bardia
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract We evaluate microsatellite instability-high (MSI-H) status with cell-free DNA (cfDNA) in metastatic breast cancer (MBC) and the association with clinico-genomic characteristics. Patients with MSI-H in cfDNA (Guardant360®, 74 gene next-gener
Externí odkaz:
https://doaj.org/article/f65bfda34691462a94c380daea7a2c6a
Publikováno v:
Case Reports in Pulmonology, Vol 2015 (2015)
A 42-year-old African American female with chronic cocaine use for 20 years, presented with two-day history of exertional shortness of breath and pleuritic chest pain. She was admitted three years back with acute kidney injury and skin rashes. At tha
Externí odkaz:
https://doaj.org/article/3a45592d442540bcacaf11473ff4eed5
Autor:
Santanu Bhattacharya, Krishnendu Pal, Anil K Sharma, Shamit K Dutta, Julie S Lau, Irene K Yan, Enfeng Wang, Ahmed Elkhanany, Khalid M Alkharfy, Arunik Sanyal, Tushar C Patel, Suresh T Chari, Mark R Spaller, Debabrata Mukhopadhyay
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114409 (2014)
GAIP interacting protein C terminus (GIPC) is known to play an important role in a variety of physiological and disease states. In the present study, we have identified a novel role for GIPC as a master regulator of autophagy and the exocytotic pathw
Externí odkaz:
https://doaj.org/article/09280cc855094a579ee67ad2cb4917df
Autor:
Heather A. Parsons, Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana Abramson, Ashka Patel, Ju Cheng, Adam M. Brufsky, Justin Rhoades, Jeremy Force, Ruolin Liu, Tiffany A. Traina, Lisa Carey, Mothaffar Rimawi, Ahmed Elkhanany, Vered Stearns, Jennifer M. Specht, Harold Burstein, Antonio C. Wolff, Eric Winer, Nabihah Tayob, Ian Krop, Todd Golub, Erica L. Mayer, Viktor Adalsteinsson
Publikováno v:
Cancer Research. 83:PD11-06
Background. Patients (pts) with early triple negative breast cancer (eTNBC) are at increased risk of breast cancer recurrence and death. Recent studies have focused on escalation of therapy, with current treatment standard of at least five drugs –
Autor:
Jeffrey Franks, Nicole E. Caston, Ahmed Elkhanany, Travis Gerke, Andres Azuero, Gabrielle B. Rocque
Publikováno v:
Cancer Research. 83:P4-07
Purpose: There are multiple treatment options for patients with metastatic breast cancer (MBC); however, there is minimal data on the optimal sequencing. Furthermore, limited information is available to understand the influence of prior treatment dur
Autor:
Mylin A. Torres, Kevin Kalinsky, Erica Stringer-Reasor, Ahmed Elkhanany, Jolinta Lin, David M. Schuster, Sarah Friend, Jeffrey Switchenko, Manali Bhave
Publikováno v:
Cancer Research. 83:OT2-10
Background Although immunotherapy (IO) in combination with chemotherapy has improved progression free and overall survival in patients with PD-L1+ metastatic triple negative breast cancer (mTNBC), prognosis remains poor. A potential therapeutic strat
Autor:
Jeffrey Franks, Nicole E. Caston, Ahmed Elkhanany, Travis Gerke, Andres Azuero, Gabrielle B. Rocque
Publikováno v:
Breast Cancer Research and Treatment. 197:673-681
Purpose Multiple treatment options exist for patients with metastatic breast cancer (MBC). However, limited information is available on the impact of prior treatment duration and class on survival outcome for novel therapies, such as cyclin-dependent
Publikováno v:
American Society of Clinical Oncology Educational Book. :e29-e46
Persistent disparities in the burden of breast cancer between African Americans and White Americans have been documented over many decades. Features characterizing breast cancer in the African American community include a 40% higher mortality rate, y
Autor:
Jennifer K. Litton, Kenneth Offit, Christine Laronga, Matthew B. Yurgelun, Leigha Senter-Jamieson, Kristen M. Shannon, Ahmed Elkhanany, Beth Y. Karlan, Seema A. Khan, Susan M. Domchek, Kari B. Wisinski, Patricia I. Dickson, Gwen Reiser, Holly J. Pederson, Catherine Klein, Barbara S. Norquist, Mary B. Daly, Allison W. Kurian, Wendy Kohlmann, Carolyn S. Menendez, Jeffrey N. Weitzel, Mary A. Dwyer, Mollie L. Hutton, Susan Darlow, Kala Visvanathan, Sofia D. Merajver, Rebecca Shatsky, Myra J. Wick, Michael Goggins, Saundra S. Buys, Michael Berry, Susan Hatters Friedman, Julie S. Mak, Tuya Pal
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:77-102
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancreatic cancer and reco